The University of Alberta has a lot going for it. It’s pretty. And it’s home to many an eccentric and clever inventor, like Kory Mathewson. Kory is an A.I researcher who comes with a side-kick, a robot that does improv comedy. In this Hello World video, Bloomberg Businessweek's Ashlee Vance goes in search of the humorous side of artificial intelligence.
Hello World is a Webby and Emmy-nominated video series from Bloomberg that invites the viewer to come on a journey across the globe to find the inventors, scientists and technologists shaping our future. Join journalist and best-selling author Ashlee Vance on a quest to find the freshest, weirdest tech creations and the beautiful freaks behind them.
Watch more Hello World episodes: https://www.bloomberg.com/features/20...
Like this video? Subscribe to Bloomberg on YouTube: http://www.youtube.com/Bloomberg?sub_...
Bloomberg is the First Word in business news, delivering breaking news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
I had the chance to work a bit with Kory many years ago doing improv, and I've gotta say this thing looks very cool! He's a great guy, and this tech will only keep developing from here, but such an interesting way to combine two of his interests in doing improv and computer science! Way to be man!
I get that Kory thinks his enthusiastic talking and charisma can fill the gap and make up for the fact that this is really just Siri inside a store-bought robot toy and _not_ A.I., but I'm just not buying any of this b.s. of it doing stand-up or possessing any level of intelligence: Blueberry's responses are mostly off because it's not really intelligent or conscious at all. Making it quote lines from movies is a neat way to make it seem more relatable and aware of phrasing and culture, but that's really just a sort of a randomized text-to-speech algorithm coupled with voice recognition capabilities. Putting this voice inside a moving plastic robot makes it seem real to anybody who doesn't understand computers or A.I. But it's not A.I. and it's nothing new.
totally incoherent gibberish.. it isn't intelligent, it isn't funny, it isn't artificial "intelligence".. you may laugh once in a 100 or 1000 tries because COINCIDENTALLY it says something that's kinda related, witty or unexpected, but it surely doesn't do so on purpose, like a human would.. and that's how you get a phd nowadays, wow
I appreciate this guy's knowledge but one particular thing I want to say is.. don't create emotional intelligence to machines.. its OK to have robots around us without emotional intelligence ..but emotional intelligence in a machine will lead to a path of human destruction....!
Patients taking Viagra are less likely to suffer a heart attack, new research claims.
Men taking the impotence drug were found to have a lower risk of having a heart attack or dying from heart failure than those not on the medication.
The findings mean Viagra could soon be used to treat hundreds of thousands of heart failure patients and even prevent fatal heart attacks, scientists say.
Experts from the University of Manchester studied 6,000 diabetic patients who had been given Viagra to treat erectile dysfunction.
The drug relaxes muscle cells in the blood vessels supplying the penis, allowing more blood to flow there.
This increased blood flow increases the likelihood of getting an erection.
Given the increasing reports of deaths in which the use of Viagra may be implicated, clinicians need to exercise caution when advising their patients with heart
Experts believe a key ingredient in Viagra called PDE5i, which relaxes blood vessels, also prevents damage to heart cells.
Heart failure is caused by the heart failing to pump enough blood around the body at the right pressure.
It most often occurs because the heart muscle has become too weak or stiff to work properly and is usually treated with medication which supports the heart.
Despite diabetics being prone to heart problems, the study participants did not suffer as many incidents as similar patients not on the drug.